Swing To Trade
  • Stock
  • Politics
  • Business
  • Sports
Business

UnitedHealth says it is facing DOJ investigation over Medicare billing practices

by admin July 24, 2025
July 24, 2025

UnitedHealth Group revealed Thursday it is facing a Justice Department investigation over its Medicare billing practices.

It comes after the Wall Street Journal reported in May that the Department of Justice is conducting a criminal investigation into the health-care giant over possible Medicare fraud. In response at the time, the company said it stands “by the integrity of our Medicare Advantage program.”

In July, the Journal also reported that the DOJ interviewed several doctors about UnitedHealth’s practices and whether they felt pressured to submit claims for certain conditions that bolstered payments from the Medicare Advantage program to the company.

That marked the second time this year that the insurer’s Medicare Advantage business has come under federal scrutiny. The Journal also reported in February that the DOJ is conducting a civil investigation into whether the company inflated diagnoses to trigger extra payments to its Medicare Advantage plans.

But in March, UnitedHealth moved a step closer to ending a yearslong legal battle with the DOJ that began with a whistleblower who alleged the company illegally withheld at least $2 billion through the Medicare Advantage program. A special master assigned to the case by the judge issued a recommendation in favor of UnitedHealth, saying the DOJ lacked evidence.

UnitedHealthcare’s Medicare and retirement segment, which includes the Medicare Advantage business, is UnitedHealth Group’s largest revenue driver, raking in $139 billion in sales last year.

The update in the probe comes after a tumultuous last year for UnitedHealthcare, the nation’s largest and most powerful private health insurer. Shares of UnitedHealthcare’s parent company, UnitedHealth Group, are down more than 42% for the year after it suspended its 2025 forecast amid skyrocketing medical costs, announced the surprise exit of former CEO Andrew Witty and grappled with the reported probe into its Medicare Advantage business.

The company’s 2024 wasn’t any easier, marked by a historic cyberattack and the torrent of public blowback after the murder of UnitedHealthcare’s CEO Brian Thompson.

This post appeared first on NBC NEWS

previous post
Jim Cramer warns Kohl’s stock short sellers are playing with fire
next post
Businesses are cautiously spending on corporate travel as trade uncertainty looms

Related Posts

Alphabet beats earnings expectations, raises spending forecast

July 25, 2025

Uber will let women drivers and riders request...

July 25, 2025

UnitedHealth says it faces DOJ investigation over Medicare...

July 25, 2025

Businesses are cautiously spending on corporate travel as...

July 24, 2025

Credit card startup Imprint beats big banks for...

July 24, 2025

Lawsuit says Clorox hackers got passwords simply by...

July 24, 2025

Orange juice importer says Brazil tariffs will squeeze...

July 22, 2025

Musk’s brain implant company filed as a ‘disadvantaged...

July 19, 2025

A flagging U.S. industry looks for new life...

July 18, 2025

Coca-Cola dodges after Trump says soda will switch...

July 18, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Meta to halt political ads in EU from October 2025 amid legal uncertainty

      July 25, 2025
    • Here’s why the Coursera stock price has surged and its next target

      July 25, 2025
    • What is Lip-Bu Tan doing for Intel stock that’s different from Pat Gelsinger?

      July 25, 2025
    • LIDR stock skyrockets 150% after Nvidia deal, but analysts are still cautious: here’s why

      July 25, 2025
    • London’s heat-stricken underground commute threatens its appeal

      July 25, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 SwingToTrade.com All Rights Reserved.

    Swing To Trade
    • Stock
    • Politics
    • Business
    • Sports